Sign up for Table of Contents Alerts.
Email this page
Print this page
Commentary
Benefits of the Combination of Thalidomide plus Cyclophosphamide in Hormone Refractory Prostate Cancer Patients
Tania Al-Chalabi and William D. Figg
volume 6 | issue 3
March 2007Pages: 318 - 319
We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:
Download PDFIf the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.
Commentary to:
Thalidomide in Combination with Oral Daily Cyclophosphamide in Patients with Pretreated Hormone Refractory Prostate Cancer: A Phase I Clinical Trial
Giuseppe Di Lorenzo, Riccardo Autorino, Michele De Laurentiis, Valeria Forestieri, Carmela Romano, Antonella Prudente, Francesco Giugliano, Ciro Imbimbo, Vincenzo Mirone and Sabino De Placido
We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:
Download PDFIf the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.